| scholarly article | Q13442814 |
| P2093 | author name string | G. Williams | |
| J. D. Sallis | |||
| P2860 | cites work | The effect of imidodiphosphate (PNP) on the precipitation and dissolution of calcium phosphate vitro | Q71633568 |
| Transphosphorylation from nucleoside Di- and triphosphates by apatite crystals | Q78966046 | ||
| Stabilization of amorphous calcium phosphate by Mg and ATP | Q39164059 | ||
| A thermodynamic analysis of the amorphous to crystalline calcium phosphate transformation | Q39191035 | ||
| Effect of proteoglycans on in vitro hydroxyapatite formation | Q39676088 | ||
| Inhibitors and promoters of stone formation | Q39728243 | ||
| Inhibition of apatite formation by phosphorylated metabolites and macromolecules | Q40031614 | ||
| Precipitation of calcium phosphates from electrolyte solutions. III. Radiometric studies of the kinetics of precipitation and aging of calcium phosphates | Q40337462 | ||
| Structure--activity relationship of inhibitors of hydroxyapatite formation | Q42880387 | ||
| The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals | Q44967804 | ||
| Effect of phospholipids on the transformation of amorphous calcium phosphate to hydroxyapatitein vitro | Q46281103 | ||
| Inositol Phosphates and Phytic Acid as Inhibitors of Biological Calcification in the Rat | Q46283443 | ||
| The inhibition of calcium hydroxypatite crystal growth by polyphosphonates and polyphosphates | Q46286515 | ||
| Isolation from urine of pyrophosphate, a calcification inhibitor | Q46291664 | ||
| A structural basis for the transphosphorylation of nucleotides with hydroxyapatite | Q68597344 | ||
| Calcium phosphate formation in vitro. II. Effects of environment on amorphous-crystalline transformation | Q68616253 | ||
| Theory of chromatography of rigid molecules on hydroxyapatite columns with small loads. I. The case when virtually all molecules are adsorbed on to a single type of crystal site through a single type of adsorption group | Q68691700 | ||
| Adenylylimidodiphosphate and guanylylimidodiphosphate | Q68881695 | ||
| Comparative chemistry of amorphous and apatitic calcium phosphate preparations | Q69454229 | ||
| An electron microscopic study of the formation of amorphous calcium phosphate and its transformation to crystalline apatite | Q69534622 | ||
| The influence of multidentate organic phosphonates on the crystal growth of hydroxyapatite | Q69676779 | ||
| The growth of hydroxyapatite crystals | Q71023284 | ||
| Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxylapatite crystal growth | Q71206665 | ||
| The synthesis of unlabeled and 32P-labeled phosphocitrate and analytical systems for its identification | Q71348689 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endocrinology | Q162606 |
| Orthopedics and sports medicine | Q72419165 | ||
| P304 | page(s) | 169-177 | |
| P577 | publication date | 1982-03-01 | |
| P1433 | published in | Calcified Tissue International | Q5018771 |
| P1476 | title | Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation | |
| P478 | volume | 34 |
| Q43726785 | Adsorption and mineralization effects of citrate and phosphocitrate on hydroxyapatite |
| Q57226224 | Adsorption and modification of calcium salt crystal growth by anionic peptides and spermine |
| Q42797109 | An Avrami analysis of the effects of serum and human albumin on calcium hydroxyapatite crystal growth |
| Q71139454 | An intermediate state in hydrolysis of amorphous calcium phosphate |
| Q41810542 | Biological activities of phosphocitrate: a potential meniscal protective agent |
| Q39356298 | Bone-seeking agents for the treatment of bone disorders |
| Q34836666 | Calcium orthophosphates: crystallization and dissolution |
| Q28340892 | Carbohydrate-controlled precipitation of apatite with coprecipitation of organic molecules in human saliva: stabilizing role of polyols |
| Q70458231 | Characterization of the bisphosphonate recognition site on hydroxyapatite using radioligand binding techniques with [14C]citric acid |
| Q35794592 | Disease-modifying effects of phosphocitrate and phosphocitrate-β-ethyl ester on partial meniscectomy-induced osteoarthritis |
| Q39380934 | Dual effect of inorganic polymeric phosphate/polyphosphate on osteoblasts and osteoclasts in vitro |
| Q70190840 | Effectiveness of phosphocitrate and N-sulpho-2-amino tricarballylate, a new analogue of phosphocitrate, in blocking hydroxyapatite induced crystal growth and calcium accumulation by matrix vesicles |
| Q44356974 | Effects of analogues of inorganic phosphate and sodium ion on mineralization of matrix vesicles isolated from growth plate cartilage of normal rapidly growing chickens |
| Q36761697 | Environmental factors in the pathophysiology of recurrent idiopathic calcium urolithiasis (RCU), with emphasis on nutrition |
| Q42828847 | Fourier transform infrared imaging as a tool to chemically and spatially characterize matrix-mineral deposition in osteoblasts |
| Q34204807 | Glycochenodeoxycholic acid inhibits calcium phosphate precipitation in vitro by preventing the transformation of amorphous calcium phosphate to calcium hydroxyapatite |
| Q70335794 | Inhibition of calcium phosphate precipitation by human salivary acidic proline-rich proteins: structure-activity relationships |
| Q44587987 | Inhibition of calcium phosphate precipitation by human salivary statherin: structure-activity relationships |
| Q46293124 | Inhibition of calcium pyrophosphate dihydrate crystal formation in articular cartilage vesicles and cartilage by phosphocitrate |
| Q41952663 | Inhibition of hydroxyapatite formation by osteopontin phosphopeptides |
| Q68474251 | Inhibition of the amorphous calcium phosphate phase transformation reaction by polyphosphates and metal ions |
| Q42798382 | Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway |
| Q47337798 | Preparation and characterisation of calcium-phosphate porous microspheres with a uniform size for biomedical applications. |
| Q57228045 | Solubility of calcium salts, enamel, and hydroxyapatite in aqueous solutions of simple carbohydrates |
| Q36735807 | The Role of Brushite and Octacalcium Phosphate in Apatite Formation |
| Q36994140 | The deep-sea natural products, biogenic polyphosphate (Bio-PolyP) and biogenic silica (Bio-Silica), as biomimetic scaffolds for bone tissue engineering: fabrication of a morphogenetically-active polymer |
| Q41762504 | The effects of serum and human albumin on calcium hydroxyapatite crystal growth |
| Q55220749 | The role of inhibition by phosphocitrate and its analogue in chondrocyte differentiation and subchondral bone advance in Hartley guinea pigs. |
| Q70167599 | The synthesis and characterization of N-sulfo-2-amino tricarballylate: An analog of phosphocitrate and inhibitor of calcification |
Search more.